BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

549 related articles for article (PubMed ID: 11285240)

  • 1. Nuclear factor TDP-43 and SR proteins promote in vitro and in vivo CFTR exon 9 skipping.
    Buratti E; Dörk T; Zuccato E; Pagani F; Romano M; Baralle FE
    EMBO J; 2001 Apr; 20(7):1774-84. PubMed ID: 11285240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An intronic polypyrimidine-rich element downstream of the donor site modulates cystic fibrosis transmembrane conductance regulator exon 9 alternative splicing.
    Zuccato E; Buratti E; Stuani C; Baralle FE; Pagani F
    J Biol Chem; 2004 Apr; 279(17):16980-8. PubMed ID: 14966131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization and functional implications of the RNA binding properties of nuclear factor TDP-43, a novel splicing regulator of CFTR exon 9.
    Buratti E; Baralle FE
    J Biol Chem; 2001 Sep; 276(39):36337-43. PubMed ID: 11470789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Splicing factors induce cystic fibrosis transmembrane regulator exon 9 skipping through a nonevolutionary conserved intronic element.
    Pagani F; Buratti E; Stuani C; Romano M; Zuccato E; Niksic M; Giglio L; Faraguna D; Baralle FE
    J Biol Chem; 2000 Jul; 275(28):21041-7. PubMed ID: 10766763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SR protein-mediated inhibition of CFTR exon 9 inclusion: molecular characterization of the intronic splicing silencer.
    Buratti E; Stuani C; De Prato G; Baralle FE
    Nucleic Acids Res; 2007; 35(13):4359-68. PubMed ID: 17576688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CELF proteins regulate CFTR pre-mRNA splicing: essential role of the divergent domain of ETR-3.
    Dujardin G; Buratti E; Charlet-Berguerand N; Martins de Araujo M; Mbopda A; Le Jossic-Corcos C; Pagani F; Ferec C; Corcos L
    Nucleic Acids Res; 2010 Nov; 38(20):7273-85. PubMed ID: 20631008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional analysis of cis-acting elements regulating the alternative splicing of human CFTR exon 9.
    Niksic M; Romano M; Buratti E; Pagani F; Baralle FE
    Hum Mol Genet; 1999 Dec; 8(13):2339-49. PubMed ID: 10556281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular and viral splicing factors can modify the splicing pattern of CFTR transcripts carrying splicing mutations.
    Nissim-Rafinia M; Chiba-Falek O; Sharon G; Boss A; Kerem B
    Hum Mol Genet; 2000 Jul; 9(12):1771-8. PubMed ID: 10915765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A T3 allele in the CFTR gene exacerbates exon 9 skipping in vas deferens and epididymal cell lines and is associated with Congenital Bilateral Absence of Vas Deferens (CBAVD).
    Disset A; Michot C; Harris A; Buratti E; Claustres M; Tuffery-Giraud S
    Hum Mutat; 2005 Jan; 25(1):72-81. PubMed ID: 15580565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nuclear factor TDP-43 binds to the polymorphic TG repeats in CFTR intron 8 and causes skipping of exon 9: a functional link with disease penetrance.
    Buratti E; Brindisi A; Pagani F; Baralle FE
    Am J Hum Genet; 2004 Jun; 74(6):1322-5. PubMed ID: 15195661
    [No Abstract]   [Full Text] [Related]  

  • 11. Depletion of TDP 43 overrides the need for exonic and intronic splicing enhancers in the human apoA-II gene.
    Mercado PA; Ayala YM; Romano M; Buratti E; Baralle FE
    Nucleic Acids Res; 2005; 33(18):6000-10. PubMed ID: 16254078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined computational-experimental analyses of CFTR exon strength uncover predictability of exon-skipping level.
    Aissat A; de Becdelièvre A; Golmard L; Vasseur C; Costa C; Chaoui A; Martin N; Costes B; Goossens M; Girodon E; Fanen P; Hinzpeter A
    Hum Mutat; 2013 Jun; 34(6):873-81. PubMed ID: 23420618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of disease-associated mutations affecting an exonic splicing enhancer and two cryptic splice sites in exon 13 of the cystic fibrosis transmembrane conductance regulator gene.
    Aznarez I; Chan EM; Zielenski J; Blencowe BJ; Tsui LC
    Hum Mol Genet; 2003 Aug; 12(16):2031-40. PubMed ID: 12913074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An exonic splicing enhancer offsets the atypical GU-rich 3' splice site of human apolipoprotein A-II exon 3.
    Arrisi-Mercado P; Romano M; Muro AF; Baralle FE
    J Biol Chem; 2004 Sep; 279(38):39331-9. PubMed ID: 15247216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of a disease-associated mutation affecting a putative splicing regulatory element in intron 6b of the cystic fibrosis transmembrane conductance regulator (CFTR) gene.
    Faà V; Incani F; Meloni A; Corda D; Masala M; Baffico AM; Seia M; Cao A; Rosatelli MC
    J Biol Chem; 2009 Oct; 284(44):30024-31. PubMed ID: 19759008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding sites for Rev and ASF/SF2 map to a 55-nucleotide purine-rich exonic element in equine infectious anemia virus RNA.
    Chung H ; Derse D
    J Biol Chem; 2001 Jun; 276(22):18960-7. PubMed ID: 11278454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of common single-nucleotide polymorphisms on exon 9 and exon 12 skipping in nonmutated CFTR alleles.
    Steiner B; Truninger K; Sanz J; Schaller A; Gallati S
    Hum Mutat; 2004 Aug; 24(2):120-9. PubMed ID: 15241793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions among SR proteins, an exonic splicing enhancer, and a lentivirus Rev protein regulate alternative splicing.
    Gontarek RR; Derse D
    Mol Cell Biol; 1996 May; 16(5):2325-31. PubMed ID: 8628299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antagonistic factors control the unproductive splicing of SC35 terminal intron.
    Dreumont N; Hardy S; Behm-Ansmant I; Kister L; Branlant C; Stévenin J; Bourgeois CF
    Nucleic Acids Res; 2010 Mar; 38(4):1353-66. PubMed ID: 19965769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TDP43 depletion rescues aberrant CFTR exon 9 skipping.
    Ayala YM; Pagani F; Baralle FE
    FEBS Lett; 2006 Feb; 580(5):1339-44. PubMed ID: 16458894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.